<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35223629</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2251-6093</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Iranian journal of public health</Title><ISOAbbreviation>Iran J Public Health</ISOAbbreviation></Journal><ArticleTitle>Long COVID in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>88</StartPage><EndPage>95</EndPage><MedlinePgn>88-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18502/ijph.v51i1.8297</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to evaluate the Long COVID frequency, and related factors in patients followed up after hospitalization.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included 133 inpatients with COVID-19 PCR test positivity from Nigde Province, Turkey between 01.01.2021 and 28.02.2021. The characteristics of the patients were recorded by examining the files, and the symptom questioning was made by telephone interviewing with the patients approximately four months after the date of diagnosis. The presence of at least one symptom lasting more than four weeks was described as Long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The frequency of Long COVID was 64.7%. The most common Long COVID symptoms were fatigue (45.9%), respiratory distress (25.6%), and muscle / joint pain (24.8%), respectively. In comparison analysis to identify factors associated with Long COVID; Long COVID was found to be more frequent among women (<i>P</i>=0.04); patients with severe COVID-19 (<i>P</i>&lt;0.01), patients with prolonged hospital stay (<i>P</i>=0.03), patients with the comorbid disease (<i>P</i>=0.03), and Diabetes Mellitus patients (<i>P</i>=0.02). Additionally, the frequency of Long COVID increased as the depression score stated by the person increased after COVID-19 disease (<i>P</i>=0.02).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The treatment of COVID-19 patients should not end when they are discharged from the hospital. On the contrary, these patients, especially high-risk patients, should be followed up in post-COVID clinics and rehabilitated physically and psychosocially with a multidisciplinary approach following the recovery period of the acute illness.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Yaksi et al. Published by Tehran University of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yaksi</LastName><ForeName>Nese</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nigde Community Health Center, Nigde, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teker</LastName><ForeName>Ayse Gulsen</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine, Marmara University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imre</LastName><ForeName>Ayfer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases and Clinical Microbiology, Nigde Training and Research Hospital, Nigde, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Iran J Public Health</MedlineTA><NlmUniqueID>7505531</NlmUniqueID><ISSNLinking>2251-6085</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hospital</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Symptom</Keyword><Keyword MajorTopicYN="N">Turkey</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>28</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35223629</ArticleId><ArticleId IdType="pmc">PMC8837882</ArticleId><ArticleId IdType="doi">10.18502/ijph.v51i1.8297</ArticleId><ArticleId IdType="pii">IJPH-51-88</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer COVID-19 Coronavirus Pandemic Report  (2021). Available from: https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>Oran DP, Topol EJ. (2021). The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med, 174(5): 655&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839426</ArticleId><ArticleId IdType="pubmed">33481642</ArticleId></ArticleIdList></Reference><Reference><Citation>Godri Pollitt KJ, Peccia J, Ko AI, et al. (2020). COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Hum Genomics, 14(1):17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214856</ArticleId><ArticleId IdType="pubmed">32398162</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray MF, Kenny EE, Ritchie MD, et al. (2020). COVID-19 outcomes and the human genome. Genet Med, 22(7):1175&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629441</ArticleId><ArticleId IdType="pubmed">32393819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen A, David JK, Maden SK. (2020). Human leukocyte antigen susceptibility map for SARS-CoV-2. J Virol, 94(13): e00510&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307149</ArticleId><ArticleId IdType="pubmed">32303592</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group (2020). Persistent symptoms in patients after acute covid-19. JAMA, 324(6): 603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Godlee F. (2020). Living with covid-19. BMJ, 370: m3392.</Citation></Reference><Reference><Citation>Baig AM. (2021). Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers. J Med Virol, 93(5): 2555&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38: 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, et al. (2021). Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect, 27(2):258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Clinical management of COVID-19 interim guidance  (2020). Available from: https://apps.who.int/iris/handle/10665/332196</Citation></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. (2021). Long COVID: an overview. Diabetes Metab Syndr, 15(3): 869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, et al. (2021). Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health, 21(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. (2021). More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep, 11(1): 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey CM, Louie M, Loeb M, et al. (2007). One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med, 167(12):1312&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 397(10270):220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. (2021). Attributes and predictors of long COVID. Nat Med, 27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. (2020). Long covid: How to define it and how to manage it. BMJ, 370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. (2021). Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol, 27(1):154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. (2021). Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol, 93(2):1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. (2021). Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax, 76(4):405&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. (2021). Long COVID in the Faroe Islands-a longitudinal study among non-hospitalized patients. Clin Infect Dis, 73(11):e4058&#x2013;e4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, et al. (2021). Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect, 82(3):378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes EK, Zambrano LD, Anderson KN, et al. (2020). Coronavirus disease 2019 case surveillance&#x2014;United States, January 22&#x2013;may 30, 2020. MMWR Morb Mortal Wkly Rep, 69(24):759&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep, 69(30):993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Liu Y, Xu D, et al. (2020). Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J Radiol, 21(6):746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231610</ArticleId><ArticleId IdType="pubmed">32410413</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Cari&#xf1;ena A, Moreno E, et al. (2021). Post-COVID-19 functional status six-months after hospitalization. J Infect, 82(4):e31&#x2013;e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. (2021). Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine, 31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckler RA, Hubmayr RD. (2007). Ventilator-associated lung injury: a search for beter therapeutic targets. Eur Respir J, 30(6):1216&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18055706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>